Teleflex Incorporated (TFX)
NYSE
Closed
Oct 20, 2026
Day's Range
129.4252 wk Range
100.18Overview - TFX - Teleflex Incorporated
Key Statistics
Valuation
Enterprise Value
8.04B
P/E (Trailing)
‪2,735.59‬
P/E (Forward)
‪11.71‬
PEG Ratio
‪-157.86‬
Price / Sales (TTM)
‪2.40‬
Price / Book
‪1.87‬
EV / EBITDA
‪19.92‬
Profitability
Gross Margin
‪58.16%‬
Profit Margin
‪-45.76%‬
Operating Margin
‪10.05%‬
Return on Assets
‪1.74%‬
Return on Equity
‪-0.70%‬
Ownership
Shares Outstanding
42.37M
Float
42.21M
Short % of Shares Outstanding
‪15.00%‬
Held by Insiders
‪0.62%‬
Held by Institutions
‪114.79%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪131.44‬
200-Day Avg
‪124.08‬
Dividends
Payout Ratio
‪103.82%‬
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
‪$ 154.00‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TFX - Teleflex Incorporated
Peers - TFX - Teleflex Incorporated
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - TFX - Teleflex Incorporated
About
Teleflex Incorporated is a global leader in the development, manufacturing, and distribution of single-use medical devices, with its headquarters in Wayne, Pennsylvania. The company's core mission is to improve patient health and quality of life by providing innovative medical technologies designed for procedures in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
